Medable logo

Medable

Emerging

Medable raised $304M to build the leading decentralized clinical trial (DCT) platform, enabling remote patient participation, eConsent, and wearable data integration for pharmaceutical trials.

Best for: Clinical TrialsEmerging, rapid growth
42
AI Score
Grade C↑ Trending
AI Visibility Score (Beta)
Artificial IntelligenceClinical TrialsWebsiteUpdated April 2026

Brand Intelligence Graph

Competes with
Capabilities
Clinical Trials

Company Overview

About Medable

Medable provides the technology infrastructure for decentralized clinical trials (DCTs) — enabling pharmaceutical companies to conduct trials where patients participate from home rather than traveling to research sites. The platform covers the full DCT workflow: electronic informed consent (eConsent), remote patient monitoring via wearables, telemedicine visits, electronic clinical outcome assessments (eCOA), and direct-to-patient drug delivery coordination.

Business Model & Competitive Advantage

Founded in 2013 and headquartered in Palo Alto, Medable accelerated rapidly during COVID-19 when the industry was forced to adopt remote trial capabilities. The company has raised $304M total and serves most of the top 20 pharmaceutical companies. Its technology has been used in over 500 trials across oncology, rare disease, neurology, and cardiovascular medicine.

Competitive Landscape 2025–2026

Decentralized trials can reduce patient dropout rates by 30–50% and cut site costs significantly by eliminating geography as a barrier to participation. Medable competes with Veeva Vault EDC, Oracle Clinical One, and Signant Health but differentiates through its purpose-built DCT platform and deep regulatory expertise in remote trial conduct across FDA, EMA, and PMDA jurisdictions.

Founded
2013
Headquarters
Palo Alto, Medable accelerated rapidly during COVID
Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Medable is an emerging player bringing innovative solutions to the Enterprise AI market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

42
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Compare Medable with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Medable

Claim This Profile

Are you from Medable? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Medable Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Medable vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →